Common and distinct fronto-striatal volumetric changes in heroin and cocaine use disorders.

Autor:	Ceceli AO; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Huang Y; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Kronberg G; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Malaker P; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Miller P; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., King SG; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Gaudreault PO; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., McClain N; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Gabay L; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Vasa D; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Newcorn JH; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Ekin D; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Alia-Klein N; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Goldstein RZ; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jazyk:	angličtina
Zdroj:	Brain : a journal of neurology [Brain] 2023 Apr 19; Vol. 146 (4), pp. 1662-1671.
DOI:	10.1093/brain/awac366
Abstrakt:	Different drugs of abuse impact the morphology of fronto-striatal dopaminergic targets in both common and unique ways. While dorsal striatal volume tracks with addiction severity across drug classes, opiates impact ventromedial prefrontal cortex (vmPFC) and nucleus accumbens (NAcc) neuroplasticity in preclinical models, and psychostimulants alter inhibitory control, rooted in cortical regions such as the inferior frontal gyrus (IFG). We hypothesized parallel grey matter volume changes associated with human heroin or cocaine use disorder: lower grey matter volume of vmPFC/NAcc in heroin use disorder and IFG in cocaine use disorder, and putamen grey matter volume to be associated with addiction severity measures (including craving) across both. In this cross-sectional study, we quantified grey matter volume (P < 0.05-corrected) in age/sex/IQ-matched individuals with heroin use disorder (n = 32, seven females), cocaine use disorder (n = 32, six females) and healthy controls (n = 32, six females) and compared fronto-striatal volume between groups using voxel-wise general linear models and non-parametric permutation-based tests. Overall, individuals with heroin use disorder had smaller vmPFC and NAcc/putamen volumes than healthy controls. Bilateral lower IFG grey matter volume patterns were specifically evident in cocaine versus heroin use disorders. Correlations between addiction severity measures and putamen grey matter volume did not reach nominal significance level in this sample. These results indicate alterations in dopamine-innervated regions (in the vmPFC and NAcc) in heroin addiction. For the first time we demonstrate lower IFG grey matter volume specifically in cocaine compared with heroin use disorder, suggesting a signature of reduced inhibitory control, which remains to be tested directly using select behavioural measures. Overall, results suggest substance-specific volumetric changes in human psychostimulant or opiate addiction, with implications for fine-tuning biomarker and treatment identification by primary drug of abuse. (© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu